A new article published in Dermatology and Therapy discussed that facial seborrheic dermatitis (FSD) is a chronic and relapsing inflammatory skin disorder occurring in areas of the face rich in sebaceous glands. It clinically manifests as erythematous scaly macules or plaques, often associated with pruritus. This article reported that the pathogenesis of seborrheic dermatitis is not yet fully understood;Malassezia yeast, hormones, sebum levels and immune response areknown etiological factors for this condition. Additionally, drugs, cold temperatures and stress exacerbate the condition. However, available treatments do not cure the disease, but attenuate symptoms. Various pharmacological treatments—including antifungal agents, keratolytics, topical low-potency steroidsand calcineurin inhibitors—provide benefits, but they also have potential side effects. The authors stated that SD tends to have a chronic, recurrent course. The long-term use of drugs can be avoided by topical non-pharmacological products, such as cosmetics or medical devices. Products with antimicrobial and anti-inflammatory ingredients such as zinc, piroctone olamine, dihydroavenanthramide, biosaccharide gum-2and stearyl glycyrrhetinate may speed FSD recovery, improve clinical outcomes and prevent flare-ups. Furthermore, the use of specific cleansers, moisturizers and sunscreens formulated as light creams or gel/creams should be strongly recommended to all FSD patients.